Allergic Bronchopulmonary Aspergillosis

Disease-a-Month

Volumn 54, Issue 8, 2008, Pages 547-564

  Lazarus, Angeline A ^a   Thilagar, Bennett ^a   McKay, Sean A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; INFLUENZA VACCINE; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE; OMALIZUMAB; PNEUMOCOCCUS VACCINE; PREDNISONE; VORICONAZOLE;

ADRENAL INSUFFICIENCY; ASPERGILLUS; ASTHMA; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CUSHING SYNDROME; CYSTIC FIBROSIS; DRUG DOSE REDUCTION; DYSPNEA; EXERCISE TOLERANCE; FEVER; HEMOPTYSIS; HUMAN; HYGIENE; LUNG FUNCTION; LUNG INFILTRATE; PAIN; PATHOGENESIS; RECOMMENDED DRUG DOSE; REMISSION; REVIEW; SPUTUM; THORAX RADIOGRAPHY; WHEEZING;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASTHMA; BIOPSY, NEEDLE; BRONCHOGRAPHY; COMBINED MODALITY THERAPY; COMORBIDITY; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RADIOGRAPHY, THORACIC; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47049114234     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.05.004     Document Type: Review

References (58)

1. Zmeili O.S., and Soubani A.O. Pulmonary Aspergillosis: a clinical update. Q J Med 100 (2007) 317-4
2. Hinson K.F.W., Moon A.J., and Plummer N.S. Bronchopulmonary aspergillosis. Thorax 7 (1952) 317-333
3. Pepys J., Riddel R.W., Ciron K.M., et al. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis 80 (1959) 167-180
4. McCarthy D.S., and Pepys J. Allergic bronchopulmonary aspergillosis: clinical immunolohgy: 1. Clinical features. Clin Allergy 1 (1971) 261-286
5. Schwartz H.J., and Greenberger P.A. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 117 (1991) 138-142
6. Greenberger P.A., and Patterson R.J. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81 (1988) 646-650
7. Becker J.W., Burke W., McDonald G., et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 109 (1996) 1536-1540
8. Basich J.E., Graves T.S., Baz M.N., et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 68 (1981) 98-102
9. Halwig M.J., Kurup V.P., Greenberger P.A., et al. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Int Med 76 (1985) 55-58
10. Shah A., Khan Z.U., Chaturvedi S., et al. Concomitant allergic aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. Ann Allergy 64 6 (1990) 507-551
11. Chauhan B., Santiago L., Kirschmann D.A., et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 159 (1997) 4072-4076
12. Chauhan B., Santiago L., Hutcheson P.S., et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 106 (2000) 723-729
13. Chauhan B., Knutsen A.P., Hutcheson P.S., et al. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 97 (1996) 2324-2331
14. Stevens D.A., Moss R.B., Kurup V.P., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: cystic fibrosis foundation. Consensus conference. Clin Infect Dis 37 suppl (2003) S225-S264 3
15. Beaumont F., Kauffman H.F., de Monchy J.G.R., et al. Volumetric aerobiological survey of conidal fungi in the North-East Netherlands. II: Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy 40 (1985) 181-186
16. Kauffman H.F., Tomee J.F., van der Werf T.S., et al. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 151 6 (1995) 2109-2115 discussion 2116
17. Gibson P.G., Wark P.A.B., Simpson J.L., et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 21 (2003) 582-588
18. Denning D.W., O'Driscoll B.R., Hogaboam C.M., et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27 (2006) 615-626
19. Greenberger P.A. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110 (2002) 685-692
20. Gibson P.G. Allergic bronchopulmonary aspergillosis. Semin Respir Crit Care Med 27 2 (2006) 185-190
21. Slavin R.G., Hutcheson P.S., Chauhan B., et al. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 25 6 (2004) 395-399
22. Kumar R. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis. A clinical and serologic evaluation. Chest 124 (2003) 890-892
23. Bahous J., Malo J.L., Paquin R., et al. Allergic bronchopulmonary aspergillosis and sensitization to Aspergillus fumigatus in chronic bronchiectasis in adults. Clin Allergy 15 (1985) 571-579
24. Vlahakis N.E., and Aksamit T.R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 76 (2001) 930-938
25. Greenberger P.A., Miller T.P., Roberts M., et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 70 (1993) 333-338
26. Patterson R., Greenberger P.A., Radin R.C., et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Int Med 96 (1982) 286-291
27. Lee T.M., Greenberger P.A., Patterson R., et al. Stage V (fibrotic) allergic bronchopulmonary aspergillosis: a review of 17 cases followed from diagnosis. Arch Intern Med 147 (1987) 319-323
28. Geller D.E., Kaplowitz H., Light M.J., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Reported prevalence, regional distribution, and patient characteristics. Chest 116 (1999) 639-646
29. Nepomuceno I.B., Esrig S., and Moss R.B. Allergic bronchopulmonary aspergilosis in cystic fibrosis. Role of atopy and response to itraconazole. Chest 115 (1999) 364-370
30. Skov M., Pressler T., Jensen H.E., et al. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 54 (1999) 44-50
31. Marchant J.L., Warner J.O., and Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis. Thorax 49 (1994) 1002-1005
32. Kraemer R., Delosea N., Ballinari P., et al. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 174 (2006) 1211-1220
33. Morrissey B., and Evans S. Severe bronchiectasis. Clin Rev Allergy Immunol 25 (2003) 233-247
34. Franquet T., Muller N.L., Gimenez A., et al. Spectrum of pulmonary aspergillosis: histologic, clinical and radiologic findings. Radiographics 21 (2001) 825-837
35. Al-Alawi A., Ryan C.F., Flint J.D., et al. Aspergillus-related lung disease. Can Respir J 12 (2005) 377-387
36. Panchal N., Bhagat R., Pant C., et al. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 91 (1997) 213-219
37. Ward S., Heyneman L., Lee M.J., et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 173 (1999) 937-942
38. Angus R.M., Davies M.L., Cowan M.D., et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to aspergillosus fumigates. Thorax 49 (1994) 586-589
39. Logan P.M., and Muller N.L. High attenuation mucous plugging in allergic bronchopulmonary aspergillosis. Can Assoc Radiol J 47 (1996) 374-377
40. Neeld D.A., Goodman L.R., Gurney J.W., et al. Computed tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 142 (1990) 1200-1205
41. Webb W.R., Müller N.L., and Naidich D.P. High-Resolution CT of the Lung. (ed 3) (2001), Lippincott Williams & Wilkins, Philadelphia, PA 505-508
42. Webb W.R. High resolution tomography of obstructive lung disease. Rad Clin North Am 32 (1994) 745-757
43. Agarwal R., Gupta D., Aggarwal A.N., et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis. Chest 132 (2007) 1183-1190
44. Stevens D.A., Kan V.L., Judson M.A., et al. Practice guidelines for diseases caused by aspergillus. Infectious Diseases Society of America. Clin Infect Dis 30xu 4 (2000) 696-709
45. Judson M.A., and Stevens D.A. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Exp Opin Pharmacother 2 7 (2001) 1065-1071
46. Ricketti A.J., Greenberger P.A., and Patterson R. Serum IgE as an important aid in the management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74 (1984) 68-71
47. Patterson R., Greenberger P.A., Lee T.M., et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 80 (1987) 663-668
48. Seaton A., Seaton R.A., and Wightman A.J.A. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow up. Q J Med 87 (1994) 529-537
49. Thomson J.M., Wesley A., Byrnes C.A., et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulm 41 (2006) 164-170
50. Salez F., Brichet A., Desurmont S., et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 116 (1999) 1665-1668
51. Stevens D.A., Schwartz H.J., Lee J.Y., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 342 (2000) 756-762
52. Wark P.A.B., Hensley M.J., Saltos N., et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 111 (2003) 952-957
53. Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 98 (2004) 915-923
54. Wark P.A.B., Gibson P.G., and Wilson A.J. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 3 (2004) CD001108
55. Bolland M.J., Bagg W., Thomas M.G., et al. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother 38 (2004) 46-49
56. Skov M., Main K.M., Silleson I.B., et al. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budenoside. Eur Respir J 20 (2002) 127-133
57. Hilliard T., Edwards S., Buchdahl R., et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 4 4 (2005) 215-220 [Epub 2005 Oct 20]
58. Van der Ent C.K., Hoekstra H., and Rijkers G.T. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant ant-IgE antibody. Thorax 62 (2007) 276-277